PARIS, 3rd April 2024: Despite challenging market conditions, our team has achieved success in completing over 60 transactions in the past 12 months across our core sectors: Software & Fintech, Healthcare, Energy Transition & Sustainability, Industrial Tech, Business & Tech-Enabled Services, and NextGen Consumer. With our recent growth, we’re poised at the forefront of the fastest-growing sectors, ready to maximise our global impact with team enhancements. To further strengthen our global presence and enhance service offerings, we are proud to announce the appointment of two Partners in Technology and Healthcare Investment Banking – Jonathan Bohbot and Paul de Mestier. In total, the bank employs over 200 people in Europe and the USA, with 16 partners and 20 Managing Directors.
Greg Revenu, Co-founder and Managing Partner of Bryan, Garnier & Co, comments “The appointments of Jonathan Bohbot and Paul de Mestier are a recognition of their transactional successes, their commitment to excellence for our clients, and their ability to embody the values of Bryan, Garnier & Co. We have confidence in their ability to make a significant contribution to the group’s future development.”
Olivier Garnier, Founder and Managing Partner of Bryan, Garnier & Co, adds “The development of our partnership structure has been a pillar of Bryan Garnier’s success since its establishment. The appointment of partners who have spent their careers at Bryan Garnier highlights exemplary career paths and strengthens the group’s culture. Jonathan Bohbot is an aspirational example for all our employees. The appointment of Paul de Mestier, who joined us in the last 3 years, further enriches the prospects of the partnership by recognising the contribution of new talent who have demonstrated a remarkable ability to make a positive impact on the group.”
Jonathan Bohbot
Investment Banking I Software and Tech-Enabled Services
Jonathan is a seasoned investment banker with over 15 years of expertise in the financial advisory sector, joining Bryan, Garnier & Co in 2015 where he has contributed to the rapid growth of the bank’s Software and Tech-Enabled Services practices. He became Managing Director in 2021 and then Partner in 2024.
Prior to this, he spent 5 years in PwC’s Audit and Transaction Services teams in Paris. Over the course of his career, Jonathan has advised on more than thirty M&A, LBO and fundraising transactions. He has specialised in the software, consulting and IT services sectors.
Jonathan holds a Master’s degree in Management from ESCP Europe, and a Master’s degree in Corporate Finance from the University of Wisconsin in 2012.
Jonathan states “At Bryan, Garnier & Co, one of our greatest strengths is our ability to build strong and long-term relationships with our clients, as demonstrated by the many deals we have done with SWORD and EasyVista over the past 18 and 10 years respectively. As a partner, my goal is to continue reinforcing Bryan Garnier’s leadership in the software and IT services sector. I also intend to support more entrepreneurs in the early stages of their development, with the aim of advising them in the long term, as we have already succeeded in doing for so many years. Overall, my goal is to work with our teams to strengthen the level of service and custom advice that we deliver to our clients every day.”
Paul de Mestier
Investment Banking | Healthcare
With over 10 years’ investment banking experience working with European healthcare companies, Paul joined Bryan, Garnier & Co as Managing Director in 2021, contributing to the development of the healthcare practice on the M&A front.
He was previously Associate Director in Mergers and Acquisitions for the healthcare department of financial group Philippe Hottinguer. He began his career as a Healthcare Analyst at ABN AMRO Bank in 2012, where he became Head of Relationships in 2014, covering French family healthcare companies.
Throughout his career, Paul has specialised in mergers and acquisitions, particularly in healthcare services for both pharmaceutical companies and patient care groups.
He obtained a Master’s degree in International Finance from ESCE Paris in 2012.
Paul states “Bryan, Garnier & Co is a benchmark in the sector and leads the way in European healthcare ECM transactions, with landmark deals such as Moderna, BioNTech and Abivax. Coming from a pure M&A background, my aim as a partner is to help strengthen the bank’s healthcare M&A activities. I firmly believe that specialisation by constantly developing expertise and knowing the ecosystem inside out pays off in the long term. I will continue to develop our teams internationally so that we can continue to support European growth companies.”
About Bryan, Garnier & Co
Bryan, Garnier & Co is a European growth investment bank that helps healthcare and technology companies become global champions. By combining extensive sector expertise with an entrepreneurial mindset, Bryan Garnier provides companies and their investors with independent growth strategic advice, and privileged access to buyers and capital in Europe, the US and Asia.
As a full-service investment bank, the firm offering includes private and public growth financing solutions, mergers and acquisitions (M&A) advisory, research insights, and institutional sales & execution. Founded in 1996, Bryan Garnier & Co is an independent partnership with around 200 employees located in major financial centres in Europe and the US.